The Radio of RDW/ALB: A Cost-Effective Biomarker for Early-Stage Risk Stratification in Acute Ischemic Stroke
Tao Ding,Xueqin Hu,Lihua Shao,Jun Wen,Jun Xia,Ning Zhou,Jiayi Yang,Li Zhang
DOI: https://doi.org/10.2147/ijgm.s486495
IF: 2.145
2024-09-28
International Journal of General Medicine
Abstract:Tao Ding, 1 Xueqin Hu, 2 Lihua Shao, 1 Jun Wen, 1 Jun Xia, 2 Ning Zhou, 1 Jiayi Yang, 1 Li Zhang 1 1 Department of Neurology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, Hunan, 415000, People's Republic of China; 2 Department of Neurosurgery, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, Hunan, 415000, People's Republic of China Correspondence: Li Zhang, Department of Neurology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, Hunan, People's Republic of China, Tel +86-18229603176, Fax +86-0736-7788483, Email Background and Aims: The red blood cell distribution width (RDW) to albumin (ALB) ratio (RAR) has been identified as a prognostic indicator for mortality in critically ill patients across various diseases. Nevertheless, the impact of RAR on clinical functional prognosis in Acute ischemic stroke (AIS) remains uncertain. This study aimed to evaluate the prognostic significance of RAR in AIS patients. Methods: A secondary analysis was performed on a cohort study, involving 1906 AIS patients recruited from a South Korean academic hospital. Both univariate and multivariate logistic regression was employed to assess the connections between RAR and negative functional results in AIS. To explore potential non-linear relationships in this association, a generalized additive model (GAM) and smooth curve fitting were utilized. Further, a mediation analysis was performed to identify possible mediators. Results: Out of the 1906 eligible patients, 546 (28.65%) were found to have an unfavorable prognosis. Patients with elevated RAR had a higher likelihood of facing a negative prognosis in AIS (all P< 0.001). RAR demonstrated a dose-response relationship with the probability of poor functional prognosis. When analysis of RAR as a continuous variable, an increase in RAR was correlated with a higher risk of adverse prognosis.When RAR was analyzed as quartile variables, the highest RAR remained an independent contributing factor for both 3-month unfavorable outcomes (adjusted OR, 1.4; 95% CI: 1.0– 2.1, P=0.046) and 3-month mortality (adjusted OR, 5.2; 95% CI, 2.0– 13.9; p< 0.001). More interestingly, the presence of a pro-inflammatory state may serve as a mediator in the connections between RAR and adverse functional outcomes. Conclusion: Given its cost-effectiveness and ease of measurement, baseline RAR holds promise as a valuable biomarker for early risk assessment in AIS patients. Keywords: acute ischemic stroke, RDW/ALB, adverse functional outcomes, dose-response relationship, biomarker Stroke is still the second most common cause of death and the main reason for adult-onset disability worldwide, leading to substantial economic and medical challenges for both individuals and society. 1,2 From 1990 to 2019, the Global Burden of Diseases (GBD) data revealed significant increases in stroke statistics: incident strokes rose by 70%, prevalent strokes by 85%, stroke-related deaths by 43%, and DALYs by 32%. 2 In 2010 in China, the estimated prevalence of stroke was 2.6%, with an incidence rate of 505.2 per 100,000 person-years and a mortality rate of 343.4 per 100,000 person-years. 3 Acute ischemic stroke (AIS), stemming from cerebral artery occlusion or ischemic cerebral hypoperfusion, constitutes over 80% of all strokes. 4 Research has shown that 40% of AIS patients fail to achieve functional independence despite advancements in therapeutic approaches. 5 The identification of precise predictors of functional prognosis in AIS patients has the potential to optimize treatment decisions, enhance clinical care, and simplify recovery and discharge planning. 6 Hence, finding a dependable prognostic indicator to forecast the functional outlook of AIS patients is crucial. Routine blood tests often include an assessment of the red blood cell distribution width (RDW). It provides an accurate and objective reflection of the size variability of peripheral red blood cells. The typical range of RDW in most clinical laboratories falls between 11% and 15%, 7 and an elevation in RDW may indicate involvement in various detrimental biological pathways, such as inflammation, 8 oxidative stress, 9 telomere shortening, 10 nutritional deficiencies, 11 and erythropoietin deficiency or dysfunction. 12 There is evidence that elevated RDW levels are closely correlated to the occurrence and recurrence of -Abstract Truncated-
medicine, general & internal